Moderna (MRNA)
(Delayed Data from NSDQ)
$125.00 USD
-0.59 (-0.47%)
Updated May 3, 2024 04:00 PM ET
After-Market: $125.10 +0.10 (0.08%) 7:12 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Brokerage Reports
Moderna, Inc. [MRNA]
Reports for Purchase
Showing records 1 - 20 ( 254 total )
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Gene Juice: The Importance of Delivery Vectors - AAVs, LNPs, eVLPs, PNPs, and More
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for MRNA 21224
Provider: Stock Traders Daily
Analyst: Research Department
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for MRNA 12224
Provider: Stock Traders Daily
Analyst: Research Department
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Moderna, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for MRNA 1224
Provider: Stock Traders Daily
Analyst: Research Department